Management of Hypertriglyceridemia with Low HDL and Elevated LDL/HDL Ratio

Assessment of Cardiovascular Risk

The patient's lipid panel shows moderate hypertriglyceridemia, which exceeds the desirable level of <150 mg/dL, according to the American Diabetes Association 1, 2
The HDL cholesterol is significantly low, with optimal levels being >40 mg/dL for men and >50 mg/dL for women, as recommended by the American Heart Association 1, 3
The LDL/HDL ratio is 2.4, which is within normal range, but the low HDL component represents a significant cardiovascular risk factor, as stated by the American College of Cardiology 3
This pattern of dyslipidemia is commonly associated with insulin resistance, metabolic syndrome, and type 2 diabetes, according to the American Diabetes Association 1

Implement dietary changes focusing on reduction of saturated fat and simple carbohydrates, as recommended by the American Family Physician 2, 4
Recommend weight loss if the patient is overweight or obese, according to the American Family Physician 2, 5
Increase physical activity, which can help raise HDL levels, as stated by the American Diabetes Association 6
Advise complete smoking cessation if applicable, as recommended by the American Heart Association 3

Fibrates, such as fenofibrate, are the first-line pharmacological treatment for this lipid profile with elevated triglycerides and low HDL, as recommended by the American Family Physician 2, 4
Fibrates can effectively reduce triglyceride levels and increase HDL cholesterol, according to the American Diabetes Association 7, 6

Reduce triglycerides to <150 mg/dL, as recommended by the American Diabetes Association 1, 3
Increase HDL cholesterol to >40 mg/dL in men (>50 mg/dL in women), according to the American Heart Association 1, 3
Maintain LDL cholesterol <100 mg/dL, as recommended by the American College of Cardiology 1, 7

Reassess lipid panel 4-12 weeks after initiating therapy, as stated by the American Diabetes Association 6
Once goals are achieved, monitor every 6-12 months, according to the American Diabetes Association 6
Evaluate liver function and creatine kinase levels when using fibrates or statins, as recommended by the American Diabetes Association 8

For patients with combined elevated LDL, triglycerides, and low HDL, statins may be considered, with potential addition of fibrates or niacin, as recommended by the American Diabetes Association 9
The American Diabetes Association suggests that for diabetic patients with dyslipidemia, improved glycemic control can be very effective for reducing triglyceride levels 9
The combination of statins with fibrates increases the risk of myositis; lower statin doses should be used with this combination, according to the American Diabetes Association 9
For patients with triglyceride levels >400 mg/dL, strong consideration should be given to pharmacological treatment to minimize the risk of pancreatitis, as recommended by the American Diabetes Association 9

Reduce triglycerides to <150 mg/dL, as recommended by the American Diabetes Association 9